Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2023-02-09 11:41 am Sale | 13G | IDEAYA BIOSCIENCES INC IDYA | ADAGE CAPITAL PARTNERS GP L.L.C. | 2,201,559 4.58% | -250,000 (-10.20%) | View |
2023-02-01 10:58 am Purchase | 13G | IDEAYA BIOSCIENCES INC IDYA | FEDERATED HERMES INC. FHI | 2,864,500 5.95% | 574,218 (+25.07%) | View |
2023-01-31 1:58 pm Purchase | 13G | IDEAYA BIOSCIENCES INC IDYA | BlackRock Inc. BLK | 3,536,730 7.4% | 807,011 (+29.56%) | View |
2022-10-27 4:30 pm Purchase | 13G | IDEAYA BIOSCIENCES INC IDYA | ADAGE CAPITAL PARTNERS GP L.L.C. | 2,451,559 5.16% | 2,451,559 (New Position) | View |
2022-05-02 4:59 pm Purchase | 13G | IDEAYA BIOSCIENCES INC IDYA | BIOTECHNOLOGY VALUE FUND L P | 1,964,859 5.1% | 1,964,300 (+351395.35%) | View |
2022-03-18 5:04 pm Purchase | 13G | HARPOON THERAPEUTICS INC HARP | Logos Global Management LP | 2,650,000 6.9% | 1,150,000 (+76.67%) | View |
2022-02-18 5:17 pm Purchase | 13G | IDEAYA BIOSCIENCES INC IDYA | Point72 Asset Management L.P. | 2,054,217 5.3% | 2,054,217 (New Position) | View |
2022-02-14 2:34 pm Purchase | 13G | IDEAYA BIOSCIENCES INC IDYA | PRICE T ROWE ASSOCIATES INC | 2,701,525 7% | 2,701,525 (New Position) | View |
2022-02-14 1:43 pm Purchase | 13G | IDEAYA BIOSCIENCES INC IDYA | FEDERATED HERMES INC. FHI | 2,290,282 5.95% | 2,290,282 (New Position) | View |
2022-02-14 09:18 am Purchase | 13G | IDEAYA BIOSCIENCES INC IDYA | Avidity Partners Management LP | 2,553,000 6.6% | 82,821 (+3.35%) | View |
2022-02-14 08:43 am Purchase | 13G | IDEAYA BIOSCIENCES INC IDYA | RTW INVESTMENTS LP | 2,520,076 6.5% | 423,233 (+20.18%) | View |
2022-02-11 8:19 pm Sale | 13G | IDEAYA BIOSCIENCES INC IDYA | BIOTECHNOLOGY VALUE FUND L P | 559 1% | -1,787,000 (-99.97%) | View |
2022-02-04 4:12 pm Purchase | 13G | IDEAYA BIOSCIENCES INC IDYA | BlackRock Inc. BLK | 2,729,719 7.1% | 2,729,719 (New Position) | View |
2021-12-01 11:04 am Purchase | 13G | IDEAYA BIOSCIENCES INC IDYA | Avidity Partners Management LP | 2,470,179 6.4% | 2,470,179 (New Position) | View |
2021-08-11 4:31 pm Sale | 13D | IDEAYA BIOSCIENCES INC IDYA | 5AM Ventures IV L.P. | 1,398,066 3.7% | -408,650 (-22.62%) | View |
2021-04-29 4:29 pm Sale | 13G | IDEAYA BIOSCIENCES INC IDYA | BIOTECHNOLOGY VALUE FUND L P | 1,787,559 5.4% | -1,439,210 (-44.60%) | View |
2021-04-05 5:27 pm Purchase | 13G | IDEAYA BIOSCIENCES INC IDYA | BRISTOL MYERS SQUIBB CO BMY | 1,633,254 5.1% | 1,633,254 (New Position) | View |
2021-02-16 4:00 pm Sale | 13G | IDEAYA BIOSCIENCES INC IDYA | Nextech V Oncology S.C.S. SICAV-SIF | 0 0% | -1,403,823 (Position Closed) | View |
2021-02-16 3:38 pm Sale | 13G | IDEAYA BIOSCIENCES INC IDYA | PERCEPTIVE ADVISORS LLC | 0 0% | -1,141,484 (Position Closed) | View |
2021-02-11 5:06 pm Purchase | 13G | IDEAYA BIOSCIENCES INC IDYA | BIOTECHNOLOGY VALUE FUND L P | 3,226,769 11.1% | 2,597 (+0.08%) | View |